RootsAnalysishas done a detailed study on Cell and Advanced Therapies SupplyChain Management Market: Focus on Technological Solutions (CellOrchestration Platforms, Enterprise Manufacturing Systems, Inventory ManagementSystems, Laboratory Information Management Systems, Logistics ManagementSystems, Patient Management Systems, Quality Management Systems, Tracking &Tracing Systems, and Other Software), 2019-2030, covering key aspects of the industry’sevolution and identifying potential future growth opportunities.
Toorder this 510+ page report, which features 185+ figures and 400+ tables,please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Key Market Insights
§ Presently, over 160 innovative, software-enabled systemsare being used to efficiently manage and streamline various aspects of thecomplex supply chain of cell and advanced therapies
§ Company involved in this domain are putting in significantefforts to develop advanced software solutions and also differentiate theirofferings, from those of other industry players, in order to maintain acompetitive edge
§ North America is the major hub of innovation in this field,serving as the base for companies of all sizes, which are primarily engaged indeveloping cloud-based solutions for diverse applications
§ The cell and advanced therapies market is characterized byan elaborate value chain, involving a multitude of processes and severalstakeholders, each having a discrete set of priorities and requirements
§ Increase in partnership activityreflects the growing interest of stakeholders in this industry; over 50% ofreported deals were established to deploy software solutions for enhancingvisibility and supply chain performance
§ An analysis of recent activity on Twitter reveals theincreasing interest and ongoing efforts of industry stakeholders in providingneedle-to-needle traceability and supply chain orchestration solutions
§ Given their cost saving potentialacross different processes and operations, we expect the cell and advancedtherapy supply chain solutions market to grow at an annualized rate of around 25%over the next decade
§ In the mid-long term, the projected opportunity isanticipated to be well distributed across various global regions, different enduses / applications and mode of deployment of various proprietary softwaresolutions
For more information, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
